Failure with the new triphasic oral contraceptive Logynon.
نویسندگان
چکیده
منابع مشابه
Natazia®: a New Combination Oral Contraceptive
JALYN® (DUTASTERIDE/TAMSULOSIN): A NEW OPTION IN BPH n the U.S., the leading method of contraception is the combination oral contraceptive pill. More than 10 million women aged 15-44 years use the birth control pill as their primary method of contraception.1 Since the first BCP approval in 1960, the FDA has approved many oral contraceptive products. Most of these products use ethinyl estradiol ...
متن کاملDecreased maximal aerobic capacity with use of a triphasic oral contraceptive in highly active women: a randomised controlled trial.
BACKGROUND Oral contraceptives are commonly used by women athletes. However, their effect on athletic performance is unclear. OBJECTIVES To examine the effects of a moderate dose, triphasic oral contraceptive on measures of athletic performance in highly trained women athletes. METHODS This is a double blind, placebo controlled trial in 14 women with ovulatory menstrual cycles and maximal a...
متن کاملAntibiotics and oral contraceptive failure - a case-crossover study.
BACKGROUND Evidence on the association between antibiotic use and combined oral contraceptive (COC) failure is controversial. We examined the effect of concomitant antibiotic treatment on the risk of breakthrough pregnancy among COC users. STUDY DESIGNS We performed a case-crossover study of 1330 COC failure cases among 17,721 women from the Slone Epidemiology Center Birth Defects Study (1997...
متن کاملA New Contraceptive Method
هدف این مقاله تهیه اطلاعات مستند و آزمایشات بالینی ایالات متحده روی مدروکسی پروژسترون استات (MPA) و استرادیول سیپونات (E2C) می باشد که به MPA-E2C معروف است.این دارو اولین کنتراسپتیو هورمونی (پروژسترون-استروژن) ترکیبی تزریقی ماهیانه است که علاوه بر ارائه نحوه استفاده از آن باسایر روشهای پیشگیری و تزریقی DMPA نیز مقایسه شده است.
متن کاملDrug interaction with oral contraceptive steroids.
A number of major studies in the past 4 years have facilitated assessment of drug interactions with the steroids in oral contraceptive (OCs). In 8 women receiving a single dose of Minovlar during rifampicin therapy and another dose 1 month after stopping rifampicin, rifampicin reduced the half-life of norethisterone from 6.2 to 3.2 hours, the half-life of ethinyl estradiol (EE) from 6.5 to 2.9...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1982
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.284.6308.17-a